These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23042303)

  • 21. Vitamin D-Binding Protein and Risk of Renal Cell Carcinoma in the Cancer Prevention Study-II Cohort.
    Mondul AM; Weinstein SJ; Parisi D; Um CY; McCullough ML; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1203-1207. PubMed ID: 30030213
    [No Abstract]   [Full Text] [Related]  

  • 22. Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers.
    Stolzenberg-Solomon RZ; Weinstein S; Pollak M; Tao Y; Taylor PR; Virtamo J; Albanes D
    Am J Epidemiol; 2008 Nov; 168(9):1047-55. PubMed ID: 18801887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking?
    Nogueira LM; Newton CC; Pollak M; Silverman DT; Albanes D; Männistö S; Weinstein SJ; Jacobs EJ; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):914-922. PubMed ID: 28096201
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum Concentrations of Per- and Polyfluoroalkyl Substances and Risk of Renal Cell Carcinoma.
    Shearer JJ; Callahan CL; Calafat AM; Huang WY; Jones RR; Sabbisetti VS; Freedman ND; Sampson JN; Silverman DT; Purdue MP; Hofmann JN
    J Natl Cancer Inst; 2021 May; 113(5):580-587. PubMed ID: 32944748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women?
    Gaudet MM; Falk RT; Gierach GL; Lacey JV; Graubard BI; Dorgan JF; Brinton LA
    Cancer Epidemiol; 2010 Oct; 34(5):580-6. PubMed ID: 20579950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohort.
    Muller DC; Fanidi A; Midttun Ø; Steffen A; Dossus L; Boutron-Ruault MC; Severi G; Kühn T; Katzke V; de la Torre RA; González CA; Sánchez MJ; Dorronsoro M; Santiuste C; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Giotaki M; Trichopoulos D; Palli D; Krogh V; Tumino R; Vineis P; Panico S; Tjønneland A; Olsen A; Bueno-de-Mesquita HB; Peeters PH; Ljungberg B; Wennberg M; Weiderpass E; Murphy N; Riboli E; Ueland PM; Boeing H; Brennan P; Johansson M
    Am J Epidemiol; 2014 Oct; 180(8):810-20. PubMed ID: 25205830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis.
    Perumal K; Huin WK; Yap NY; Ong TA; Gobe GC; Rajandram R
    Med Hypotheses; 2019 Aug; 129():109239. PubMed ID: 31371068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis.
    Yap NY; Yap FN; Perumal K; Rajandram R
    Biomarkers; 2019 Sep; 24(6):607-614. PubMed ID: 31215811
    [No Abstract]   [Full Text] [Related]  

  • 29. Association of leptin, visfatin, apelin, resistin and adiponectin with clear cell renal cell carcinoma.
    Zhang HP; Zou J; Xu ZQ; Ruan J; Yang SD; Yin Y; Mu HJ
    Oncol Lett; 2017 Jan; 13(1):463-468. PubMed ID: 28123583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies.
    Purdue MP; Moore LE; Merino MJ; Boffetta P; Colt JS; Schwartz KL; Bencko V; Davis FG; Graubard BI; Janout V; Ruterbusch JJ; Beebe-Dimmer J; Cote ML; Shuch B; Mates D; Hofmann JN; Foretova L; Rothman N; Szeszenia-Dabrowska N; Matveev V; Wacholder S; Zaridze D; Linehan WM; Brennan P; Chow WH
    Int J Cancer; 2013 Jun; 132(11):2640-7. PubMed ID: 23150424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Luhn P; Dallal CM; Weiss JM; Black A; Huang WY; Lacey JV; Hayes RB; Stanczyk FZ; Wentzensen N; Brinton LA
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1304-12. PubMed ID: 23696194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma.
    Hsueh YM; Chen WJ; Lin YC; Huang CY; Shiue HS; Yang SM; Ao PL; Pu YS; Su CT
    Toxicol Appl Pharmacol; 2018 Jul; 350():11-20. PubMed ID: 29723618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tobacco use in relation to renal cell carcinoma.
    Yuan JM; Castelao JE; Gago-Dominguez M; Yu MC; Ross RK
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):429-33. PubMed ID: 9610793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case-control study of occupation/industry and renal cell carcinoma risk.
    Karami S; Colt JS; Schwartz K; Davis FG; Ruterbusch JJ; Munuo SS; Wacholder S; Stewart PA; Graubard BI; Rothman N; Chow WH; Purdue MP
    BMC Cancer; 2012 Aug; 12():344. PubMed ID: 22873580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking, environmental tobacco smoke, and risk of renal cell cancer: a population-based case-control study.
    Theis RP; Dolwick Grieb SM; Burr D; Siddiqui T; Asal NR
    BMC Cancer; 2008 Dec; 8():387. PubMed ID: 19108730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case-Control Study.
    Scelo G; Muller DC; Riboli E; Johansson M; Cross AJ; Vineis P; Tsilidis KK; Brennan P; Boeing H; Peeters PHM; Vermeulen RCH; Overvad K; Bueno-de-Mesquita HB; Severi G; Perduca V; Kvaskoff M; Trichopoulou A; La Vecchia C; Karakatsani A; Palli D; Sieri S; Panico S; Weiderpass E; Sandanger TM; Nøst TH; Agudo A; Quirós JR; Rodríguez-Barranco M; Chirlaque MD; Key TJ; Khanna P; Bonventre JV; Sabbisetti VS; Bhatt RS
    Clin Cancer Res; 2018 Nov; 24(22):5594-5601. PubMed ID: 30037816
    [No Abstract]   [Full Text] [Related]  

  • 37. Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis.
    Callahan CL; Hofmann JN; Corley DA; Zhao WK; Shuch B; Chow WH; Purdue MP
    Cancer Epidemiol; 2018 Oct; 56():31-37. PubMed ID: 30029068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study.
    Luc G; Empana JP; Morange P; Juhan-Vague I; Arveiler D; Ferrieres J; Amouyel P; Evans A; Kee F; Bingham A; Machez E; Ducimetiere P
    Int J Obes (Lond); 2010 Jan; 34(1):118-26. PubMed ID: 19823188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overweight and obesity during adolescence increases the risk of renal cell carcinoma.
    Landberg A; Fält A; Montgomery S; Sundqvist P; Fall K
    Int J Cancer; 2019 Sep; 145(5):1232-1237. PubMed ID: 30790271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating obesity-driven biomarkers are associated with risk of clear cell renal cell carcinoma: a two-stage, case-control study.
    Wang Q; Tu H; Zhu M; Liang D; Ye Y; Chang DW; Long Y; Wu X
    Carcinogenesis; 2019 Oct; 40(10):1191-1197. PubMed ID: 31001636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.